Creative Planning’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Creative Planning’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,000	Closed	-$2K	–	4902
2016 Q4	$2K	Buy	+1,000	New	+$39.9K	﹤0.01%	4304
2016 Q3	–	Sell	-1,000	Closed	-$3K	–	4727
2016 Q2	$3K	Buy	+1,000	New	+$53.2K	﹤0.01%	3912
2015 Q4	–	Sell	-300	Closed	-$1K	–	4574
2015 Q3	$1K	Buy	+300	New	+$19.5K	﹤0.01%	4147
2014 Q4	–	Sell	-2,000	Closed	-$12K	–	4341
2014 Q3	$12K	Buy	+2,000	New	+$106K	﹤0.01%	2849

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Creative Planning's TEVA Position: Q2 2026 in Review

Creative Planning increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 9.4% in Q2 2026, buying an estimated $204K and bringing the position to 71,019 shares worth $2.41M. The position accounts for ﹤0.01% of the portfolio, ranked #1937.

Creative Planning first reported a position in TEVA in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.57M in Q3 2017. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Creative Planning held 71,019 shares of Teva Pharmaceutical Industries Limited worth $2.41M as of Q2 2026.
Creative Planning bought 6,111 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $204K.
Teva Pharmaceutical Industries Limited made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #1937 holding.
Creative Planning first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and has held it in 53 quarters since.
Creative Planning's Teva Pharmaceutical Industries Limited position peaked at $4.57M in Q3 2017.
676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.